Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$457,098
-$25,958 QoQ
Shares Held
3,618
+4.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#1,416
of 2,266 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Quantum Portfolio Management LLC holds $3,261,987 across 8 Drug Manufacturers - General names. GILD ranks #4 (14.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
3,125 | $793,656 | |
| 2 | AZN |
Astrazeneca PLC
|
3,012 | $571,135 | |
| 3 | NVS |
Novartis AG
|
3,206 | $502,443 | |
| 4 | GILD |
Gilead Sciences, Inc.
This page
|
3,618 | $457,098 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,465 | $316,752 | |
| 6 | LLY |
ELI LILLY & Co
|
239 | $286,663 | |
| 7 | ABBV |
AbbVie Inc.
|
744 | $187,220 | |
| 8 | AMGN |
Amgen Inc
|
406 | $147,020 |
All Filings in GILD
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $457,098 | 3,618 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $483,056 | 3,466 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $430,203 | 3,505 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $858,030 | 7,730 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $587,943 | 5,303 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $344,889 | 3,078 | Shares | Sole | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||